Introduction historique et critique à la notion de dépression en psychiatrie

The author describes the history of the concept of depression in modern psychiatry from the end of the Age of Enlightenment until today in three parts. In the first period (1793–1854), the opposition of general delusion (mania) and partial delusion (melancholia) prevails, without the problem of changes of the affective state being an issue. Only with the work of J. Guislain, and later of W. Griesinger, does the concept of mood disorders become a categorical form in mental pathology with the idea of psychological pain. The second period (1854–1926) is distinguished firstly by the works of J.P. Falret on circular insanity, and then those of V. Magnan, J. Ségnan, J. Séglas et Ph. Chaslin in France and E. Kraepelin in Germany. This period is characterized by the classical construction of periodic manicdepressive psychosis and takes into account the opposition of mania and melancholia. In the third period (1926–1977), the influences of phenomenology, psychoanalysis and structuralism predominate. Gradually melancholia loses its place at the core of this field, in favour of the concept of depression and this change now characterizes contemporary psychiatry.     

Inhibition of RNA synthesis in yeast protoplasts by a peptide factor from Tetrahymena cells

Protoplasts of Schizosaccharomyces pombe, grown on a rich nutrient medium, were treated with a peptide factor isolated from cultures of the protozoan Tetrahymena pyriformis. The peptide factor is known to inhibit RNA synthesis in Tetrahymena. It has now been shown that the peptide factor also inhibits RNA synthesis in yeast protoplasts without affecting protein synthesis.     

Radiosensitizing and damaging effects of hyperthermia on different biological systems. Ehrlich ascites carcinoma cells

The cytotoxic and radiosensitizing effects of hyperthermia was shown on Ehrlich ascites tumor cells heated in vitro. The effect of hyperthermia resulted in the formation of local lesions in membranes of dying cells.     

Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain.

By using the yeast two-hybrid system we identified a novel protein from the human brain interacting with the C terminus of somatostatin receptor subtype 2. This protein termed somatostatin receptor interacting protein is characterized by a novel domain structure, consisting of six N-terminal ankyrin repeats followed by SH3 and PDZ domains, several proline-rich regions, and a C-terminal sterile alpha motif. It consists of 2185 amino acid residues encoded by a 9-kilobase pair mRNA; several splice variants have been detected in human and rat cDNA libraries. Sequence comparison suggests that the novel multidomain protein, together with cortactin-binding protein, forms a family of cytoskeletal anchoring proteins. Fractionation of rat brain membranes indicated that somatostatin receptor interacting protein is enriched in the postsynaptic density fraction. The interaction of somatostatin receptor subtype 2 with its interacting protein was verified by overlay assays and coimmunoprecipitation experiments from transfected human embryonic kidney cells. Somatostatin receptor subtype 2 and the interacting protein display a striking overlap of their expression patterns in the rat brain. Interestingly, in the hippocampus the mRNA for somatostatin receptor interacting protein was not confined to the cell bodies but was also observed in the molecular layer, suggesting a dendritic localization of this mRNA.